Can-Fite BioPharma Announces $4 Million Warrant Exercise
MT Newswires Live
Sep 02
Can-Fite BioPharma (CANF) agreed to the immediate exercise of warrants for up to about 1.6 million American depositary shares at $2.50 each, expected to generate about $4 million in gross proceeds, the company said Wednesday.
In connection with the transaction, Can-Fite will issue new warrants to purchase up to about 3.2 million ADSs at an exercise price of $2.50 per ADS.
The company plans to use the net proceeds for research and development, clinical trials, working capital and general corporate purposes.
The closing is expected around Thursday.
Shares of Can-Fite fell more than 15% in premarket activity Wednesday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.